| Date | Title | Description | Source |
| 11.05.2023 | Intergalactic Therapeutics to Present Preclinical Data Highl... | Lead program, IG-002 targeting ABCA4 retinopathies demonstrated long-term, persistent protein expres... | appletreep... |
| 11.05.2023 | Intergalactic Therapeutics to Present Preclinical Data Highl... | Lead program, IG-002 targeting ABCA4 retinopathies demonstrated long-term, persistent protein expres... | appletreep... |
| 20.01.2022 | Intergalactic Therapeutics Announces Scientific Advisory Boa... | BOSTON, Mass., January 20, 2022/PR NEWSWIRE/ -- Intergalactic Therapeutics, a focal non-viral gene t... | appletreep... |
| 20.01.2022 | Intergalactic Therapeutics Announces Scientific Advisory Boa... | BOSTON, Mass., January 20, 2022/PR NEWSWIRE/ -- Intergalactic Therapeutics, a focal non-viral gene t... | appletreep... |
| 20.01.2022 | Intergalactic Therapeutics Announces Scientific Advisory Boa... | BOSTON, Jan. 20, 2022 /PRNewswire/ -- Intergalactic Therapeutics, a focal non-viral gene therapy com... | marketscre... |
| 07.10.2021 | Intergalactic Therapeutics Raises $75M in Series A Funding | Intergalactic Therapeutics, a Boston, MA-based non-viral gene therapy platform, raised $75m in Serie... | finsmes.co... |
| 07.10.2021 | Intergalactic Therapeutics Inks $75M Series A |
BOSTON, MA, Intergalactic Therapeutics raises $75 million in Series A funding.
>> Click her... | vcnewsdail... |
| 07.10.2021 | ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic T... | NEW YORK and BOSTON, Mass., October 7, 2021/PR NEWSWIRE/ – ATP, a leader in life sciences venture ca... | appletreep... |
| 07.10.2021 | ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic T... | NEW YORK and BOSTON, Mass., October 7, 2021/PR NEWSWIRE/ – ATP, a leader in life sciences venture ca... | appletreep... |
